Chemical activators of FLJ32549 include a range of compounds that influence various cellular pathways leading to the protein's activation. Phorbol 12-myristate 13-acetate is a potent activator of Protein Kinase C (PKC), which can phosphorylate FLJ32549, thereby activating it. Similarly, Forskolin works by increasing cAMP levels, subsequently activating Protein Kinase A (PKA) which can also target FLJ32549 for phosphorylation and activation. Ionomycin functions by raising intracellular calcium levels, which in turn can activate calcium-dependent kinases that phosphorylate and activate FLJ32549. Okadaic Acid, by inhibiting protein phosphatases, leads to an accumulation of phosphorylated proteins, including FLJ32549, resulting in its activation. Anisomycin activates stress-activated protein kinases, which can target FLJ32549, leading to its activation through phosphorylation.
Additionally, LY294002, by inhibiting PI3K, can lead to the activation of downstream kinases that may phosphorylate FLJ32549. Rapamycin, though primarily known for inhibiting mTOR signaling, can cause a compensatory activation of certain kinases which can in turn activate FLJ32549. The cytokinin 6-Benzylaminopurine activates kinases that can phosphorylate FLJ32549, while Thapsigargin, by disrupting calcium storage, can also activate kinases that phosphorylate and activate FLJ32549. Dibutyryl-cAMP, a cAMP analog, specifically activates PKA, another kinase that can phosphorylate FLJ32549. Phosphatidic Acid, on the other hand, can activate the mTOR signaling pathway, potentially leading to the phosphorylation and activation of FLJ32549. Lastly, Calyculin A, similar to Okadaic Acid, inhibits protein phosphatases, which can result in the phosphorylation and subsequent activation of FLJ32549, highlighting the diverse range of chemical activators that can lead to the functional activation of this protein.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Directly activates Protein Kinase C (PKC) which is known to phosphorylate FLJ32549, leading to its activation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Increases intracellular calcium levels, activating kinases that could phosphorylate and thus activate FLJ32549. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Inhibits protein phosphatases leading to increased phosphorylation and activation of FLJ32549. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Activates stress-activated protein kinases which can then phosphorylate and activate FLJ32549. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits PI3K, indirectly leading to the activation of kinases that could phosphorylate and activate FLJ32549. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR signaling, which may lead to kinase activation that could phosphorylate and activate FLJ32549. | ||||||
6-Benzylaminopurine | 1214-39-7 | sc-202428 sc-202428A | 1 g 5 g | $20.00 $52.00 | ||
Activates kinases that may phosphorylate and activate FLJ32549. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Disrupts calcium storage and activates kinases that could phosphorylate and activate FLJ32549. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
A cAMP analog that activates PKA, leading to the phosphorylation and activation of FLJ32549. | ||||||
Phosphatidic Acid, Dipalmitoyl | 169051-60-9 | sc-201057 sc-201057B sc-201057A | 100 mg 250 mg 500 mg | $106.00 $244.00 $417.00 | ||
Activates mTOR signaling pathway, potentially leading to phosphorylation and activation of FLJ32549. | ||||||